Teva asks U.S. justices for stay in Copaxone case

WASHINGTON (Reuters) - Teva Pharmaceutical Industries on Monday asked the U.S. Supreme Court to stay an appeals court ruling that would strip its $4 billion-a-year multiple sclerosis drug Copaxone of its patent protection in 2014 rather than 2015.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news